• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冥想诱导的血源性因子作为新冠肺炎的辅助治疗手段。

Meditation-induced bloodborne factors as an adjuvant treatment to COVID-19 disease.

作者信息

Zuniga-Hertz Juan P, Chitteti Ramamurthy, Dispenza Joe, Cuomo Raphael, Bonds Jacqueline A, Kopp Elena L, Simpson Sierra, Okerblom Jonathan, Maurya Svetlana, Rana Brinda K, Miyonahara Atsushi, Niesman Ingrid R, Maree Jacqueline, Belza Gianna, Hamilton Hillari D, Stanton Carla, Gonzalez David J, Poirier Michelle A, Moeller-Bertram Tobias, Patel Hemal H

机构信息

Veterans Affairs San Diego Healthcare System, 3350 La Jolla Village Drive, San Diego, CA, 92161, USA.

Department of Anesthesiology, University of California, San Diego, La Jolla, CA, 92093, USA.

出版信息

Brain Behav Immun Health. 2023 Aug 7;32:100675. doi: 10.1016/j.bbih.2023.100675. eCollection 2023 Oct.

DOI:10.1016/j.bbih.2023.100675
PMID:37600600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10432704/
Abstract

The COVID-19 pandemic has resulted in significant morbidity and mortality worldwide. Management of the pandemic has relied mainly on SARS-CoV-2 vaccines, while alternative approaches such as meditation, shown to improve immunity, have been largely unexplored. Here, we probe the relationship between meditation and COVID-19 disease and directly test the impact of meditation on the induction of a blood environment that modulates viral infection. We found a significant inverse correlation between length of meditation practice and SARS-CoV-2 infection as well as accelerated resolution of symptomology of those infected. A meditation "dosing" effect was also observed. In cultured human lung cells, blood from experienced meditators induced factors that prevented entry of pseudotyped viruses for SARS-CoV-2 spike protein of both the wild-type Wuhan-1 virus and the Delta variant. We identified and validated SERPINA5, a serine protease inhibitor, as one possible protein factor in the blood of meditators that is necessary and sufficient for limiting pseudovirus entry into cells. In summary, we conclude that meditation can enhance resiliency to viral infection and may serve as a possible adjuvant therapy in the management of the COVID-19 pandemic.

摘要

新冠疫情已在全球范围内导致了严重的发病和死亡情况。疫情的管控主要依赖于新冠病毒疫苗,而诸如冥想这类被证明能增强免疫力的替代方法在很大程度上尚未得到充分探索。在此,我们探究冥想与新冠疾病之间的关系,并直接测试冥想对诱导调节病毒感染的血液环境的影响。我们发现冥想练习时长与新冠病毒感染之间存在显著的负相关,且感染人群的症状缓解加速。还观察到了冥想的“剂量”效应。在培养的人肺细胞中,有经验的冥想者的血液诱导产生了一些因子,这些因子可阻止野生型武汉 - 1病毒和德尔塔变种的新冠病毒刺突蛋白假型病毒进入细胞。我们鉴定并验证了丝氨酸蛋白酶抑制剂SERPINA5是冥想者血液中一种可能的蛋白质因子,它对于限制假病毒进入细胞是必要且充分的。总之,我们得出结论,冥想可以增强对病毒感染的抵抗力,并可能作为新冠疫情管控中的一种辅助治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696a/10432704/d8d2a24c7a90/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696a/10432704/91b89fda1d09/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696a/10432704/5eddb3593dfd/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696a/10432704/dff9b55945be/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696a/10432704/d8d2a24c7a90/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696a/10432704/91b89fda1d09/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696a/10432704/5eddb3593dfd/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696a/10432704/dff9b55945be/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/696a/10432704/d8d2a24c7a90/gr4.jpg

相似文献

1
Meditation-induced bloodborne factors as an adjuvant treatment to COVID-19 disease.冥想诱导的血源性因子作为新冠肺炎的辅助治疗手段。
Brain Behav Immun Health. 2023 Aug 7;32:100675. doi: 10.1016/j.bbih.2023.100675. eCollection 2023 Oct.
2
Therapeutic potential of green tea catechin, (-)-epigallocatechin-3--gallate (EGCG) in SARS-CoV-2 infection: Major interactions with host/virus proteases.绿茶儿茶素(-)-表没食子儿茶素-3-没食子酸酯(EGCG)在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染中的治疗潜力:与宿主/病毒蛋白酶的主要相互作用
Phytomed Plus. 2023 Feb;3(1):100402. doi: 10.1016/j.phyplu.2022.100402. Epub 2022 Dec 30.
3
The Integral Membrane Protein ZMPSTE24 Protects Cells from SARS-CoV-2 Spike-Mediated Pseudovirus Infection and Syncytia Formation.整联蛋白 ZMPSTE24 可保护细胞免受 SARS-CoV-2 刺突介导的假病毒感染和合胞体形成。
mBio. 2022 Oct 26;13(5):e0254322. doi: 10.1128/mbio.02543-22. Epub 2022 Oct 5.
4
Advax-CpG55.2-adjuvanted monovalent or trivalent SARS-CoV-2 recombinant spike protein vaccine protects hamsters against heterologous infection with Beta or Delta variants.Advax-CpG55.2 佐剂单价或三价 SARS-CoV-2 重组刺突蛋白疫苗可保护仓鼠免受 Beta 或 Delta 变异株的异源感染。
Vaccine. 2023 Nov 22;41(48):7116-7128. doi: 10.1016/j.vaccine.2023.10.018. Epub 2023 Oct 19.
5
Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白胞质尾的缺失增加了假病毒中和试验中的感染性。
J Virol. 2021 May 10;95(11). doi: 10.1128/JVI.00044-21. Epub 2021 Mar 16.
6
Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2.开发基于细胞的假病毒进入检测方法以鉴定针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的潜在病毒进入抑制剂和中和抗体。
Genes Dis. 2020 Dec;7(4):551-557. doi: 10.1016/j.gendis.2020.07.006. Epub 2020 Jul 17.
7
The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.TMPRSS2 抑制剂那法莫司他可降低 COVID-19 小鼠模型中的 SARS-CoV-2 肺部感染。
mBio. 2021 Aug 31;12(4):e0097021. doi: 10.1128/mBio.00970-21. Epub 2021 Aug 3.
8
Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells.疱疹病毒 4 型(EBV)裂解复制诱导 ACE2 表达并增强 SARS-CoV-2 假型病毒进入上皮细胞。
J Virol. 2021 Jun 10;95(13):e0019221. doi: 10.1128/JVI.00192-21.
9
Wild-type SARS-CoV-2 neutralizing immunity decreases across variants and over time but correlates well with diagnostic testing.野生型 SARS-CoV-2 中和抗体的免疫活性会随着时间推移和变异株的不同而降低,但与诊断检测有很好的相关性。
Front Immunol. 2023 Feb 8;14:1055429. doi: 10.3389/fimmu.2023.1055429. eCollection 2023.
10
Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease.SARS-CoV-2 刺突突变对其被 TMPRSS2 和替代 TMPRSS13 蛋白酶激活的影响。
mBio. 2022 Aug 30;13(4):e0137622. doi: 10.1128/mbio.01376-22. Epub 2022 Aug 1.

引用本文的文献

1
Multidimensional Analysis of Twin Sets During an Intensive Week-Long Meditation Retreat: A Pilot Study.为期一周的强化冥想静修期间双胞胎组的多维分析:一项初步研究。
Mindfulness (N Y). 2025;16(6):1634-1655. doi: 10.1007/s12671-025-02584-x. Epub 2025 May 7.
2
Cardiopulmonary and metabolic responses during a 2-day CPET in myalgic encephalomyelitis/chronic fatigue syndrome: translating reduced oxygen consumption to impairment status to treatment considerations.在肌痛性脑脊髓炎/慢性疲劳综合征的 2 天 CPET 期间的心肺和代谢反应:将耗氧量减少转化为功能障碍状态以考虑治疗。
J Transl Med. 2024 Jul 5;22(1):627. doi: 10.1186/s12967-024-05410-5.

本文引用的文献

1
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity.新冠病毒奥密克戎改变 TMPRSS2 的使用方式影响其感染性和融合性。
Nature. 2022 Mar;603(7902):706-714. doi: 10.1038/s41586-022-04474-x. Epub 2022 Feb 1.
2
High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial.大剂量伊维菌素早期治疗 COVID-19(COVER 研究):一项随机、双盲、多中心、II 期、剂量探索、概念验证临床试验。
Int J Antimicrob Agents. 2022 Feb;59(2):106516. doi: 10.1016/j.ijantimicag.2021.106516. Epub 2022 Jan 6.
3
Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants.
新冠疫苗接种对阿尔法和德尔塔变异株传播的影响。
N Engl J Med. 2022 Feb 24;386(8):744-756. doi: 10.1056/NEJMoa2116597. Epub 2022 Jan 5.
4
Large-scale genomic study reveals robust activation of the immune system following advanced Inner Engineering meditation retreat.大规模基因组研究揭示,高级内在工程冥想静修后,免疫系统会得到强有力的激活。
Proc Natl Acad Sci U S A. 2021 Dec 21;118(51). doi: 10.1073/pnas.2110455118.
5
Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients: A Randomized Clinical Trial.COVID-19 恢复期血浆治疗住院患者的疗效和安全性:一项随机临床试验。
JAMA Intern Med. 2022 Feb 1;182(2):115-126. doi: 10.1001/jamainternmed.2021.6850.
6
A snapshot of the practicality and barriers to COVID-19 interventions: Public health and healthcare workers' perceptions in high and low- and middle-income countries.COVID-19 干预措施的实用性和障碍的快照:高、中、低收入国家的公共卫生和卫生保健工作者的看法。
PLoS One. 2021 Nov 24;16(11):e0260041. doi: 10.1371/journal.pone.0260041. eCollection 2021.
7
Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA.促进 COVID-19 疫苗接种:美国 Lancet 委员会关于疫苗拒绝、接受和需求的建议。
Lancet. 2021 Dec 11;398(10317):2186-2192. doi: 10.1016/S0140-6736(21)02507-1. Epub 2021 Nov 15.
8
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion.SARS-CoV-2 B.1.617.2 德尔塔变异株复制和免疫逃逸。
Nature. 2021 Nov;599(7883):114-119. doi: 10.1038/s41586-021-03944-y. Epub 2021 Sep 6.
9
COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies.新型冠状病毒肺炎:揭开新兴的严重急性呼吸系统综合征冠状病毒 2 变种、疫苗和治疗策略的神秘面纱。
Biomolecules. 2021 Jul 6;11(7):993. doi: 10.3390/biom11070993.
10
The COVIDome Explorer researcher portal.COVIDome Explorer 研究人员门户。
Cell Rep. 2021 Aug 17;36(7):109527. doi: 10.1016/j.celrep.2021.109527. Epub 2021 Jul 28.